News | Radiation Oncology | November 23, 2015

Collaboration between physicians network and health care system offers cancer patients in the Dallas-Fort Worth metropolitan area access to IBA proton therapy 

Texas Center for Proton Therapy Now Treating Patients

IBA (Ion Beam Applications S.A.) announced that the newly opened Texas Center for Proton Therapy is now treating cancer patients, using image-guided Pencil Beam Scanning (PBS).

The 63,000-square-foot facility features a three-room Proteus PLUS proton therapy system consisting of one fixed-beam treatment room and two 360° isocentric gantry treatment rooms. Special care has been taken to incorporate an environmental-friendly design, construction, operation and maintenance of the facility, making Texas Center for Proton Therapy the first stand-alone LEED-Certified proton therapy center in the U.S.

PBS availability in all three rooms makes Texas Center for Proton Therapy the largest pencil beam proton center in the state. This highly-precise delivery modality allows for Intensity Modulated Proton Therapy (IMPT) and is furthermore supported by an on-board Cone Beam CT (CBCT) offering 3-D volumetric imaging. The configuration also includes some of the most advanced PET/CT and 3-Tesla MRI scanning and imaging technology available, as well as on-site lab services. A skilled staff, combining more than 70 years of proton experience, ensures optimal clinical use of this advanced technology.

The first gantry room is installed, and is equipped with a universal nozzle, allowing PBS, as well as Double Scattering (DS) treatment modes. The rigging was done on July 1st, 2014, the first patients being treated only 16 months later, three months in advance of the initial schedule. Treatment in the second gantry is anticipated in the 1st quarter of 2016.

Andrew K. Lee, M.D., M.P.H., medical director at Texas Center for Proton Therapy, commented: “The benefits of proton therapy for cancer treatment include the ability to treat cancer with utmost precision, minimizing damage to healthy tissue and enhancing quality of life for patients during and after treatment. New technologies from IBA allow us to better leverage this beneficial treatment, and a fully equipped center like this is an important boost to cancer treatment in Texas.”

Gary Barlow, director at Texas Center for Proton Therapy, commented: “Lacking any local access to proton therapy, residents of Dallas-Fort Worth previously had no choice but to travel if they wanted to benefit from this radiation treatment modality. We are thrilled to see our efforts fulfilled and patients benefitting from this advanced technology. We are looking forward to gradually building up our activities toward our full capacity to treat more than 100 patients a day.”

Olivier Legrain, IBA’s CEO, said: “It is our mission to make proton therapy accessible to every patient who can benefit from it. It is very satisfying to know that 6.5 million people will no longer need to travel long distances at great expense if they are in need of proton therapy treatment. IBA is proud to be a partner in bringing this advantageous treatment modality within their vicinity. Every new center treating patients is another battle won in the worldwide fight against cancer.”

Beth Klein, president of IBA Proton Therapy North America, adds: “IBA is proud to play a role in providing our state of the art technology to the physicians of Texas Center for Proton Therapy. We expect to see more collaborative partnerships in the future that provide the highest quality proton therapy treatment at a cost that ultimately may prove to be lower than conventional radiation therapy treatment for some cancers.”

For more information: www.TexasCenterforProtonTherapy.com


Related Content

News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Therapy

April 12, 2024 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery, and ...

Time April 12, 2024
arrow
News | Artificial Intelligence

April 9, 2024 —PreciseDx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for ...

Time April 09, 2024
arrow
News | Artificial Intelligence

April 8, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time April 08, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is a snapshot of the Top 10 most-read content from ITN's viewers during the month of March: 1. Philips Teams with ...

Time April 04, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
Subscribe Now